Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females

<table>Seroconversion and antibody response to HPV 16/18 in males compared to females [<a href="/journals/isrn/2011/457204/#B128">132</a>]. GMT means geometric mean titer measured at month 7, one month after the third dose of Cervarix. All subjects were seronegative at study entry. Data based on ATP immunogenicity cohort [<a href="/journals/isrn/2011/457204/#B128">132</a>]. ATP means according to protocol.</table>

International Scholarly Research Notices

fig10

Figure 10

Figure 10: Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females 